Posts by: Magdalena Kegel, PhD

Magdalena Kegel, PhD

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

May 25, 2017May 25, 2017

Esbriet Subgroup Analyses Suggest Benefits Also in Moderate and Severe IPF

Idiopathic Pulmonary Fibrosis, News

Patients with more severe idiopathic pulmonary fibrosis (IPF) also benefit from Esbriet (pirfenidone) treatment, as do IPF patients with moderate lung function impairment, according to two studies presented at the ... Read more

November 11, 2016November 11, 2016

Tiny Lab-grown Human Lungs Transplanted into Mice, Advancing Disease Research

Asthma, News

University researchers have successfully transplanted a set of miniature lab-grown human lungs derived from stem cells into mice — a feat that will lead to more specific studies of various ... Read more

October 4, 2016October 4, 2016

How Compound in Grapes and Wine Prevents Bacteria-Triggered Airway Inflammation Identified

Asthma, COPD, News

How a natural compound — resveratrol, found in grapes and red wine — works to reduce the inflammation caused by a bacterial infection that is particularly worrisome in people with airway disorders, such as asthma and ... Read more

September 2, 2016September 2, 2016

Potential Treatment for Advanced Non-Small Cell Lung Cancers Before FDA for Approval

Lung Cancer, News

ARIAD Pharmaceuticals announced that it has completed the New Drug Application for brigatinib it filed with the U.S. Food and Drug Administration (FDA), seeking market approval to use the treatment in patients with metastatic ... Read more

August 9, 2016August 9, 2016

COPD Patient Hurdles in Self-Management Needs More Research

COPD, News

Researchers from the University of Applied Sciences Utrecht, in The Netherlands, recently reported that many patients with chronic obstructive pulmonary disease (COPD) do not easily engage in self-management of the ... Read more

July 1, 2016July 1, 2016

Intestinal Stem Cells Seen to Predict CF Patients’ Response to Therapy, a Potentially Huge Step Forward

Cystic Fibrosis, News

Researchers at University Medical Center Utrecht, in the Netherlands, succeeded in using intestinal stem cells from cystic fibrosis (CF) patients to predict if patients would respond to a particular drug. The technique ... Read more

June 28, 2016June 28, 2016

P. aeruginosa Infections in CF Patients Aggravated by Workings of ‘Good’ Bacteria, Study Finds

Cystic Fibrosis, News

Bacteria that normally reside in the lungs, not causing disease, produce a compound that makes harmful bacterial infections with Pseudomonas aeruginosa difficult to fight. These infections can be particularly devastating for people ... Read more

April 29, 2016April 29, 2016

Lung Squamous Cell Carcinoma Phase 1/2 Trial to Assess Glembatumumab Vedotin Therapy

Lung Cancer, News

New Jersey-based Celldex Therapeutics recently announced the initiation of a Phase 1/2 clinical trial of glembatumumab vedotin in patients with squamous cell carcinoma. The study will focus on the safety and ... Read more

April 14, 2016April 14, 2016

Phase 3 Trial of Brigatinib for Non-Small Cell Lung Cancer Linked to ALK Mutations Is Launched by ARIAD

Lung Cancer, News

ARIAD Pharmaceuticals recently announced the start of a Phase 3 clinical trial of brigatinib for locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults with mutations in the anaplastic ... Read more

April 4, 2016April 4, 2016

Kids with Cystic Fibrosis Often Have Altered Bacterial Flora, Contributing to Symptoms in Gut

Cystic Fibrosis, News

Problems with absorbing nutrients and inflammation of the gut are hallmarks of cystic fibrosis (CF). A University of Washington study now shows that in children with cystic fibrosis, an altered gut ... Read more